1. Cohen-Dvashi H, Ben-Chetrit N, Russell R, Carvalho S, Lauriola M, Nisani S, Mancini M, Nataraj N, Kedmi M, Roth L, Köstler W, Zeisel A, Yitzhaky A, Zylberg J, Tarcic G, Eilam R, Wigelman Y, Will R, Lavi S, Porat Z, Wiemann S, Ricardo S, Schmitt F, Caldas C, Yarden Y

Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression. EMBO molecular medicine 7: 299-314, 2015.  [Article] 

 doi: 10.15252/emmm.201404134 PMID: 25678558.

 

2. Vieira AF, Ricardo S, Ablett MP, Dionísio MR, Mendes N, Albergaria A, Farnie G, Gerhard R, Cameselle-Teijeiro JF, Seruca R, Schmitt F, Clarke RB, Paredes J

P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer. Stem cells (Dayton, Ohio) 30: 854-64, 2012.  [Article] 

 doi: 10.1002/stem.1075 PMID: 22389315.

 

3. Ribeiro AS, Sousa B, Carreto L, Mendes N, Nobre AR, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Söderberg O, Seruca R, Santos MA, Schmitt F, Paredes J

P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model. The Journal of pathology 229: 705-18, 2013.  [Article] 

 doi: 10.1002/path.4143 PMID: 23180380.

 

4. Ricardo S, Marcos-Silva L, Pereira D, Pinto R, Almeida R, Söderberg O, Mandel U, Clausen H, Felix A, Lunet N, David L

Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours. Molecular oncology 9: 503-12, 2015.  [Article] 

 doi: 10.1016/j.molonc.2014.10.005 PMID: 25454345.

 

5. Coelho R, Marcos-Silva L, Mendes N, Pereira D, Brito C, Jacob F, Steentoft C, Mandel U, Clausen H, David L, Ricardo S

Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours. International journal of molecular sciences 19: ., 2018.  [Article] 

 doi: 10.3390/ijms19072045 PMID: 30011875.

 

6. Ricardo S, Marcos-Silva L, David L

Mucin carriers of TF in ovarian cancer. Journal of cancer research and clinical oncology 142: 1867-8, 2016.  [Letter] 

 doi: 10.1007/s00432-016-2186-4 PMID: 27277091.

 

7. Camilo V, Garrido M, Valente P, Ricardo S, Amaral AL, Barros R, Chaves P, Carneiro F, David L, Almeida R

Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2. Histopathology 66: 343-50, 2015.  [Article] 

 doi: 10.1111/his.12544 PMID: 25196071.

 

8. Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simões M

p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 16: 43-8, 2003.  [Article] 

 doi: 10.1097/01.MP.0000047306.72278.39 PMID: 12527712.

 

9. Marcos-Silva L, Ricardo S, Chen K, Blixt O, Arigi E, Pereira D, Høgdall E, Mandel U, Bennett EP, Vakhrushev SY, David L, Clausen H

A novel monoclonal antibody to a defined peptide epitope in MUC16. Glycobiology 25: 1172-82, 2015.  [Article] 

 doi: 10.1093/glycob/cwv056 PMID: 26201951.

 

10. Albergaria A, Ricardo S, Milanezi F, Carneiro V, Amendoeira I, Vieira D, Cameselle-Teijeiro J, Schmitt F

Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool? BMC cancer 11: 299, 2011.  [Article] 

 doi: 10.1186/1471-2407-11-299 PMID: 21762477.

 

11. Ricardo S, Marcos-Silva L, Valente C, Coelho R, Gomes R, David L

Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors. Virchows Archiv : an international journal of pathology 468: 715-22, 2016.  [Article] 

 doi: 10.1007/s00428-016-1929-6 PMID: 27003157.

 

12. Schmitt F, Ricardo S, Vieira AF, Dionísio MR, Paredes J

Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes. Virchows Archiv : an international journal of pathology 460: 545-53, 2012.  [Review] 

 doi: 10.1007/s00428-012-1237-8 PMID: 22562130.

 

13. Carvalho S, e Silva AO, Milanezi F, Ricardo S, Leitão D, Amendoeira I, Schmitt FC

c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations? Journal of clinical pathology 57: 1075-9, 2004.  [Article] 

 doi: 10.1136/jcp.2004.016378 PMID: 15452163.

 

14. Gerhard R, Ricardo S, Albergaria A, Gomes M, Silva AR, Logullo AF, Cameselle-Teijeiro JF, Paredes J, Schmitt F

Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas. Breast (Edinburgh, Scotland) 21: 354-60, 2012.  [Article] 

 doi: 10.1016/j.breast.2012.03.001 PMID: 22464177.

 

15. Ricardo SA, Milanezi F, Carvalho ST, Leitão DR, Schmitt FC

HER2 evaluation using the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas. Journal of clinical pathology 60: 1001-5, 2007.  [Article] 

 doi: 10.1136/jcp.2006.040287 PMID: 17158643.

 

16. Coelho R, Marcos-Silva L, Ricardo S, Ponte F, Costa A, Lopes JM, David L

Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment. Expert review of anticancer therapy 18: 177-186, 2018.  [Review] 

 doi: 10.1080/14737140.2018.1418326 PMID: 29241375.

 

17. Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. Journal of clinical pathology 64: 937-46, 2011.  [Article] 

 doi: 10.1136/jcp.2011.090456 PMID: 21680574.

 

18. Ricardo S, Gerhard R, Cameselle-Teijeiro JF, Schmitt F, Paredes J

Claudin expression in breast cancer: High or low, what to expect? Histology and histopathology 27: 1283-95, 2012.  [Article] 

 PMID: 22936447.

 

19. Monteiro LS, Delgado ML, Ricardo S, Garcez F, do Amaral B, Pacheco JJ, Lopes C, Bousbaa H

EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival. BioMed research international 2014: 905680, 2014.  [Article] 

 doi: 10.1155/2014/905680 PMID: 24967412.

 

20. Sousa AM, Rei M, Freitas R, Ricardo S, Caffrey T, David L, Almeida R, Hollingsworth MA, Santos-Silva F

Effect of MUC1/ß-catenin interaction on the tumorigenic capacity of pancreatic CD133(+) cells. Oncology letters 12: 1811-1817, 2016.  [Article] 

 doi: 10.3892/ol.2016.4888 PMID: 27602113.

 

21. Reis-Filho JS, Ricardo S, Gärtner F, Schmitt FC

Bilateral gonadoblastomas in a dog with mixed gonadal dysgenesis. Journal of comparative pathology 130: 229-33, 2004.  [Article] 

 doi: 10.1016/j.jcpa.2003.09.010 PMID: 15003485.

 

22. Pinheiro C, Reis RM, Ricardo S, Longatto-Filho A, Schmitt F, Baltazar F

Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. Journal of biomedicine & biotechnology 2010: 427694, 2010.  [Article] 

 doi: 10.1155/2010/427694 PMID: 20454640.

 

23. Cano G, Milanezi F, Leitão D, Ricardo S, Brito MJ, Schmitt FC

Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Diagnostic cytopathology 29: 207-11, 2003.  [Article] 

 doi: 10.1002/dc.10365 PMID: 14506673.

 

24. Preto A, Reis-Filho JS, Ricardo S, Soares P

P63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression. Pathology, research and practice 198: 449-54, 2002.  [Article] 

 PMID: 12234063.

 

25. Granja Nde M, Ricardo SA, Longatto Filho A, Alves VA, Bedrossian CW, Wiley EL, Schmitt FC

Potential use of loss of heterozygosity in pleural effusions of breast cancer metastases using the microsatellite marker of the 16q22.1 region of the CDH1 gene. Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 27: 61-6, 2005.  [Article] 

 PMID: 15913197.